SCHEMBL16410760

SCHEMBL16410760

NN1c2c(Cl)cc(Cl)cc2N=C(N=NCc2ccccc2)C12CCCCC2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16410844 0.84 — —
SCHEMBL16410566 0.79 SLC6A4 (0.33) —
SCHEMBL16410823 0.77 AMPD2 (0.34) —
SCHEMBL16410685 0.70 TSHR (0.33) —
SCHEMBL16410813 0.70 AMPD2 (0.33) —
SCHEMBL16410847 0.68 ACAT2 (0.37) —
SCHEMBL16410869 0.66 GAA (0.33) —
SCHEMBL16410646 0.66 ACAT2 (0.32) —
SCHEMBL16410625 0.66 GRIN2B (0.34) —
SCHEMBL16410631 0.66 ACAT2 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015007730-A1 SPIROQUINOXALINE DERIVATIVES AS INHIBITORS OF NON-APOPTOTIC REGULATED CELL-DEATH Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2015-01-22 — — WO disclosed
Send feedback